Deutsche Bank’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.03M | Buy |
162,758
+11,171
| +7% | +$266K | ﹤0.01% | 1411 |
|
|
2025
Q4 | $3.54M | Sell |
151,587
-36,143
| -19% | -$805K | ﹤0.01% | 1482 |
|
|
2025
Q3 | $3.7M | Buy |
187,730
+11,144
| +6% | +$229K | ﹤0.01% | 1451 |
|
|
2025
Q2 | $3.83M | Sell |
176,586
-10,215
| -5% | -$241K | ﹤0.01% | 1357 |
|
|
2025
Q1 | $4.53M | Sell |
186,801
-13,594
| -7% | -$306K | ﹤0.01% | 1290 |
|
|
2024
Q4 | $4.18M | Sell |
200,395
-377,813
| -65% | -$8.12M | ﹤0.01% | 1422 |
|
|
2024
Q3 | $11.5M | Sell |
578,208
-47,000
| -8% | -$871K | ﹤0.01% | 982 |
|
|
2024
Q2 | $9.68M | Sell |
625,208
-1,045
| -0.2% | -$16.3K | ﹤0.01% | 1017 |
|
|
2024
Q1 | $9.98M | Buy |
626,253
+7,167
| +1% | +$108K | ﹤0.01% | 1020 |
|
|
2023
Q4 | $10.4M | Buy |
619,086
+512,829
| +483% | +$7.01M | 0.01% | 978 |
|
|
2023
Q3 | $1.24M | Sell |
106,257
-854,991
| -89% | -$11.4M | ﹤0.01% | 1603 |
|
|
2023
Q2 | $12.9M | Buy |
961,248
+26,510
| +3% | +$381K | 0.01% | 897 |
|
|
2023
Q1 | $15.5M | Sell |
934,738
-146,710
| -14% | -$2.42M | 0.01% | 834 |
|
|
2022
Q4 | $20.1M | Sell |
1,081,448
-62,203
| -5% | -$958K | 0.01% | 760 |
|
|
2022
Q3 | $14.7M | Buy |
1,143,651
+1,094,054
| +2,206% | +$13M | 0.01% | 843 |
|
|
2022
Q2 | $348K | Sell |
49,597
-3,686
| -7% | -$27K | ﹤0.01% | 2819 |
|
|
2022
Q1 | $442K | Sell |
53,283
-5,840
| -10% | -$41.3K | ﹤0.01% | 2821 |
|
|
2021
Q4 | $400K | Buy |
59,123
+3,101
| +6% | +$20.4K | ﹤0.01% | 2974 |
|
|
2021
Q3 | $297K | Sell |
56,022
-1,793
| -3% | -$9.8K | ﹤0.01% | 3344 |
|
|
2021
Q2 | $332K | Sell |
57,815
-9,841
| -15% | -$50.8K | ﹤0.01% | 3482 |
|
|
2021
Q1 | $312K | Sell |
67,656
-5,906
| -8% | -$23.5K | ﹤0.01% | 3386 |
|
|
2020
Q4 | $245K | Buy |
73,562
+15,712
| +27% | +$52.8K | ﹤0.01% | 3358 |
|
|
2020
Q3 | $172K | Buy |
57,850
+5,798
| +11% | +$22.7K | ﹤0.01% | 3298 |
|
|
2020
Q2 | $240K | Sell |
52,052
-435,255
| -89% | -$1.96M | ﹤0.01% | 3044 |
|
|
2020
Q1 | $1.88M | Sell |
487,307
-2,272
| -0.5% | -$9.32K | ﹤0.01% | 1745 |
|
|
2019
Q4 | $1.83M | Buy |
489,579
+461,609
| +1,650% | +$2.16M | ﹤0.01% | 2017 |
|
|
2019
Q3 | $146K | Sell |
27,970
-58,142
| -68% | -$310K | ﹤0.01% | 3369 |
|
|
2019
Q2 | $330K | Sell |
86,112
-38,148
| -31% | -$165K | ﹤0.01% | 3530 |
|
|
2019
Q1 | $631K | Sell |
124,260
-1,804
| -1% | -$5.3K | ﹤0.01% | 3304 |
|
|
2018
Q4 | $241K | Sell |
126,064
-201,570
| -62% | -$577K | ﹤0.01% | 3781 |
|
|
2018
Q3 | $1.24M | Buy |
327,634
+132,621
| +68% | +$416K | ﹤0.01% | 3164 |
|
|
2018
Q2 | $608K | Sell |
195,013
-568,963
| -74% | -$1.73M | ﹤0.01% | 3738 |
|
|
2018
Q1 | $1.82M | Buy |
763,976
+101,474
| +15% | +$337K | ﹤0.01% | 2931 |
|
|
2017
Q4 | $2.59M | Buy |
662,502
+216,095
| +48% | +$714K | ﹤0.01% | 2550 |
|
|
2017
Q3 | $1.12M | Sell |
446,407
-206,204
| -32% | -$566K | ﹤0.01% | 2931 |
|
|
2017
Q2 | $1.8M | Buy |
652,611
+515,823
| +377% | +$1.08M | ﹤0.01% | 2625 |
|
|
2017
Q1 | $266K | Buy |
+136,788
| New | +$174K | ﹤0.01% | 3430 |
|
|
2016
Q4 | – | Sell |
-15,000
| Closed | -$16K | – | 4933 |
|
|
2016
Q3 | $16K | Sell |
15,000
-330,445
| -96% | -$298K | ﹤0.01% | 4585 |
|
|
2016
Q2 | $245K | Sell |
345,445
-91,701
| -21% | -$73.9K | ﹤0.01% | 3664 |
|
|
2016
Q1 | $510K | Buy |
437,146
+80,716
| +23% | +$125K | ﹤0.01% | 3202 |
|
|
2015
Q4 | $872K | Sell |
356,430
-383,474
| -52% | -$1.1M | ﹤0.01% | 2967 |
|
|
2015
Q3 | $2.22M | Buy |
739,904
+334,003
| +82% | +$1.44M | ﹤0.01% | 2416 |
|
|
2015
Q2 | $1.68M | Buy |
405,901
+163,408
| +67% | +$651K | ﹤0.01% | 2604 |
|
|
2015
Q1 | $1.05M | Buy |
242,493
+4,693
| +2% | +$16.9K | ﹤0.01% | 2854 |
|
|
2014
Q4 | $706K | Hold |
237,800
| – | – | ﹤0.01% | 3440 |
|
|
2014
Q3 | $789K | Buy |
237,800
+187,800
| +376% | +$491K | ﹤0.01% | 3183 |
|
|
2014
Q2 | $126K | Hold |
50,000
| – | – | ﹤0.01% | 4417 |
|
|
2014
Q1 | $113K | Buy |
+50,000
| New | +$105K | ﹤0.01% | 4175 |
|
|
2013
Q4 | – | Sell |
-47,529
| Closed | -$144K | – | 5436 |
|
|
2013
Q3 | $144K | Buy |
+47,529
| New | +$80K | ﹤0.01% | 4274 |
|
Other funds holding CPRX
VCM
DM
VPM
Deutsche Bank's CPRX Position: Q1 2026 in Review
Deutsche Bank increased its Catalyst Pharmaceutical (CPRX) stake by 7.4% in Q1 2026, buying an estimated $266K and bringing the position to 162,758 shares worth $4.03M. The position accounts for ﹤0.01% of the portfolio, ranked #1411.
Deutsche Bank first reported a position in CPRX in Q3 2013 and has held it in 49 quarters since. The position peaked at $20.1M in Q4 2022. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.
- Deutsche Bank held 162,758 shares of Catalyst Pharmaceutical worth $4.03M as of Q1 2026.
- Deutsche Bank bought 11,171 Catalyst Pharmaceutical shares in Q1 2026, an estimated $266K.
- Catalyst Pharmaceutical made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #1411 holding.
- Deutsche Bank first reported a position in Catalyst Pharmaceutical in Q3 2013 and has held it in 49 quarters since.
- Deutsche Bank's Catalyst Pharmaceutical position peaked at $20.1M in Q4 2022.
- 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.
Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.